Xencor Inc
XNCR
NASDAQ
Biotechnology
$23.34
USD
+0.35 (+1.52%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.70B
Volume 443.1K
Revenue
$104.97M
TTM
-28.6%
YoY
Gross Margin
100%
TTM
0.0%
YoY
Net Income
$-163.32M
TTM
+5.6%
YoY
Operating Cash Flow
$-205.81M
TTM
-57.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 43.6 | 21.0 | 28.2 | 4.5 | 51.2 |
YoY Growth | +82.4% | +18.0% | -46.5% | -86.2% | +17.5% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 43.6 | 21.0 | 28.2 | 4.5 | 51.2 |
Selling, General & Administrative | 15.1 | 14.2 | 17.0 | 17.7 | 16.4 |
Other Operating Expenses | 1.9 | 0.0 | 0.0 | 0.0 | 0.8 |
Total Operating Expenses | 78.6 | 68.5 | 81.9 | 82.4 | 89.1 |
Operating Income | -35.0 | -47.5 | -53.6 | -77.9 | -37.9 |
EBITDA | -30.5 | -44.9 | -51.1 | -75.3 | -34.6 |
Other Income / Expense | 5.0 | 42.6 | 50.5 | -51.5 | 18.5 |
Total Other Income / Expense | 4.0 | 41.5 | 49.4 | -50.8 | 15.9 |
Income Before Income Taxes | -31.1 | -6.0 | -4.3 | -128.6 | -21.9 |
Income Taxes | -0.3 | 0.0 | 2.4 | 0.3 | -0.2 |
Net Income | -30.8 | -6.0 | -6.7 | -128.9 | -21.7 |
Consolidated Net Income / Loss | -30.8 | -6.0 | -6.7 | -128.9 | -21.7 |
Net Income Attributable to Common Shareholders | -30.8 | -6.0 | -6.7 | -128.9 | -21.7 |
Basic EPS | -$0.41 | -$0.08 | -$0.09 | -$1.71 | -$0.29 |
Diluted EPS | -$0.41 | -$0.08 | -$0.09 | -$1.71 | -$0.29 |
Basic Shares Outstanding | 74.3M | 74.4M | 74.6M | 75.2M | 75.9M |
Diluted Shares Outstanding | 74.3M | 74.4M | 74.6M | 75.2M | 75.9M |